Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

One Drop Acquires Sano

One Drop Has Acquired All the Assets and Intellectual Property of Sano Intelligence, Inc. Which Include Sano’s Continuous Glucose Sensing Platform

Related Posts
1 of 40,578

One Drop, a leader in digital care solutions for people living with diabetes and other chronic conditions, announced it has acquired all of the assets and intellectual property of Sano Intelligence, Inc., an innovator in health sensing te1`chnology. The deal was structured as an asset purchase, and several Sano team members will be joining One Drop.

The almost decade of work put into developing the Sano continuous glucose sensing platform will live on in a comprehensive multi-sensorial solution from One Drop. The planned development marks a significant milestone in One Drop’s effort to bring personalized, adaptive, integrated health solutions to people in real time via their mobile phones.

Recommended AI News: Factual + Foursquare Announce World’s Most-Powerful Location Engine Pairing

One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.

Sano and One Drop have a shared vision of transforming traditional healthcare into proactive, preventative self-care,” said Sano CEO and founder, Ashwin Pushpala. “We are excited to combine our sensor and device expertise with the strength of One Drop’s data-driven predictive capabilities and user-centered design to create a comprehensive collision avoidance system for health and wellness.”

To date, One Drop has collected 9 billion longitudinal health data points across 75 biomarkers from nearly 2.5 million users. One Drop’s continuous health sensing platform will add thousands of new data points per user per day, thereby strengthening the machine learning models behind One Drop’s predictive and adaptive support capabilities across multiple conditions.

Recommended AI News: The Digital Dollar Project Names 22 New Advisory Group Members

“Telehealth and digital self-management of chronic conditions are more important than ever, and the benefits of real-time health sensing are obvious,” said One Drop CEO and founder, Jeff Dachis. “By introducing continuous health sensing technology to One Drop’s personalized solutions for a rapidly growing variety of health issues, we can empower people to make informed, proactive choices and prevent problems before they happen.”

One Drop has expanded its diabetes solution to offer data-driven tools and personalized support for people living with type 1 diabetes, type 2 diabetes, gestational diabetes, prediabetes, high blood pressure, high cholesterol, or any combination of these conditions. At the same time, One Drop has supplemented its direct-to-consumer channels by introducing end-to-end employer and payor offerings, digital-only offerings, and broader retail availability to reach even larger populations. The company’s unique approach combines personal health coaching, connected devices, and AI-powered Predictive Insights to inspire positive behavior change.

Recommended AI News: Automation Provides A Content Lifeline For Remote Work

Comments are closed, but trackbacks and pingbacks are open.